CD106 is a 110 kD glycosylphosphatidylinositol (GPI)-linked transmembrane protein, also known as VCAM-1 and INCAM-110. It is constitutively expressed on bone marrow stromal cells, myeloid progenitors, splenic dendritic cells, activated endothelial cells, as well as some lymphocytes. CD106 expression can be upregulated on endothelial cells by inflammatory cytokines. CD106 is involved in adhesion and acts as a counter-receptor for VLA-4 (α₄/β₁ integrin) and LPAM-1 (α₄/β₇ integrin). The 429 antibody has been reported to partially block VCAM-1-mediated binding.

PRODUCT DETAILS

Clone: 429 (MVCAM.A)

Antibody Type: Monoclonal

Reactivity: Mouse

Format: Alexa Fluor 594

Host: Rat

Isotype: IgG2a, κ

Applications: IHC-F - Quality tested

Regulatory Status: RUO

Data Sheets: TDS | SDS

Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.